Prostatic coccidioidomycosis
ICD-10 B38.81 is a billable code used to indicate a diagnosis of prostatic coccidioidomycosis.
Prostatic coccidioidomycosis is a rare fungal infection caused by the Coccidioides species, primarily C. immitis and C. posadasii, which are endemic to certain regions, particularly the southwestern United States and parts of Central and South America. This condition occurs when the fungus enters the body, often through inhalation of spores, and can disseminate to various organs, including the prostate gland. Symptoms may include fever, chills, night sweats, weight loss, and localized pain in the pelvic region. In immunocompromised patients, such as those with HIV/AIDS, diabetes, or those on immunosuppressive therapy, the risk of developing disseminated coccidioidomycosis increases significantly. Diagnosis typically involves serological tests, culture, or histopathological examination of tissue samples. Treatment often includes antifungal medications such as fluconazole or itraconazole, with severe cases potentially requiring amphotericin B. Early diagnosis and appropriate antifungal therapy are crucial to prevent complications, including chronic infection or abscess formation in the prostate.
Detailed clinical notes on symptoms, travel history, and laboratory results.
Patients presenting with respiratory symptoms and subsequent prostate involvement.
Consideration of patient’s immunocompromised status and potential for disseminated disease.
Comprehensive documentation of prostate examination findings and any imaging studies.
Patients with prostatitis-like symptoms and a history of exposure to endemic areas.
Differentiating between coccidioidomycosis and other prostatic infections or conditions.
Used to confirm diagnosis in suspected cases.
Document the reason for testing and clinical findings.
Infectious disease specialists should ensure comprehensive lab results are included.
Common symptoms include fever, chills, night sweats, weight loss, and localized pelvic pain. In some cases, patients may also experience urinary symptoms.
